2023. Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Drug Cardiotoxicity Screening. Annals of Stem Cell Research. 6, 1 (Feb. 2023), 1–6. DOI:https://doi.org/10.5281/zenodo.22237966.